DORMAN PRODUCTS INC (DORM)

US2582781009 - Common Stock

90.95  +0.22 (+0.24%)

After market: 90.95 0 (0%)

Fundamental Rating

6

Taking everything into account, DORM scores 6 out of 10 in our fundamental rating. DORM was compared to 43 industry peers in the Automobile Components industry. Both the health and profitability get an excellent rating, making DORM a very profitable company, without any liquidiy or solvency issues. DORM has a decent growth rate and is not valued too expensively. These ratings would make DORM suitable for quality investing!



7

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
In the past year DORM had a positive cash flow from operations.
DORM had positive earnings in each of the past 5 years.
In the past 5 years DORM always reported a positive cash flow from operatings.

1.2 Ratios

DORM has a Return On Assets of 5.64%. This is amongst the best in the industry. DORM outperforms 83.33% of its industry peers.
DORM has a Return On Equity of 11.07%. This is amongst the best in the industry. DORM outperforms 80.95% of its industry peers.
The Return On Invested Capital of DORM (9.05%) is better than 78.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 9.32%.
Industry RankSector Rank
ROA 5.64%
ROE 11.07%
ROIC 9.05%
ROA(3y)6.23%
ROA(5y)7.1%
ROE(3y)12.27%
ROE(5y)12.03%
ROIC(3y)9.08%
ROIC(5y)9.73%

1.3 Margins

DORM has a Profit Margin of 6.70%. This is amongst the best in the industry. DORM outperforms 80.95% of its industry peers.
In the last couple of years the Profit Margin of DORM has declined.
The Operating Margin of DORM (11.15%) is better than 85.71% of its industry peers.
In the last couple of years the Operating Margin of DORM has declined.
DORM has a better Gross Margin (35.52%) than 90.48% of its industry peers.
In the last couple of years the Gross Margin of DORM has declined.
Industry RankSector Rank
OM 11.15%
PM (TTM) 6.7%
GM 35.52%
OM growth 3Y-0.77%
OM growth 5Y-7.46%
PM growth 3Y-11.86%
PM growth 5Y-13.36%
GM growth 3Y0.43%
GM growth 5Y-1.52%

7

2. Health

2.1 Basic Checks

DORM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DORM has been reduced compared to 1 year ago.
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
The debt/assets ratio for DORM has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.67 indicates that DORM is not in any danger for bankruptcy at the moment.
The Altman-Z score of DORM (3.67) is better than 83.33% of its industry peers.
DORM has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as DORM would need 3.49 years to pay back of all of its debts.
The Debt to FCF ratio of DORM (3.49) is better than 76.19% of its industry peers.
DORM has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
DORM has a Debt to Equity ratio (0.48) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.49
Altman-Z 3.67
ROIC/WACC0.81
WACC11.14%

2.3 Liquidity

A Current Ratio of 2.25 indicates that DORM has no problem at all paying its short term obligations.
DORM has a Current ratio of 2.25. This is comparable to the rest of the industry: DORM outperforms 59.52% of its industry peers.
A Quick Ratio of 1.09 indicates that DORM should not have too much problems paying its short term obligations.
DORM's Quick ratio of 1.09 is in line compared to the rest of the industry. DORM outperforms 42.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.09

5

3. Growth

3.1 Past

The earnings per share for DORM have decreased by -4.62% in the last year.
Measured over the past 5 years, DORM shows a small growth in Earnings Per Share. The EPS has been growing by 1.52% on average per year.
DORM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.30%.
The Revenue has been growing by 14.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.62%
EPS 3Y9.48%
EPS 5Y1.52%
EPS growth Q2Q55.45%
Revenue 1Y (TTM)11.3%
Revenue growth 3Y20.87%
Revenue growth 5Y14.66%
Revenue growth Q2Q-1.4%

3.2 Future

Based on estimates for the next years, DORM will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.47% on average per year.
Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y24.68%
EPS Next 2Y17.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.7%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.03, the valuation of DORM can be described as rather expensive.
DORM's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.73. DORM is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.07, DORM is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as DORM.
DORM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.03
Fwd PE 16.07

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than 64.29% of the companies in the same industry.
DORM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.13
EV/EBITDA 12.11

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DORM may justify a higher PE ratio.
DORM's earnings are expected to grow with 17.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)13.17
EPS Next 2Y17.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (5/3/2024, 7:00:01 PM)

After market: 90.95 0 (0%)

90.95

+0.22 (+0.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.82B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.03
Fwd PE 16.07
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.81
PEG (5Y)13.17
Profitability
Industry RankSector Rank
ROA 5.64%
ROE 11.07%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.15%
PM (TTM) 6.7%
GM 35.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.25
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-4.62%
EPS 3Y9.48%
EPS 5Y
EPS growth Q2Q
EPS Next Y24.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.3%
Revenue growth 3Y20.87%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y